尿道灌注治疗慢性前列腺炎的疗效分析  

Analyzing Urethral Perfusion for the Treatment of Chronic Protatitis

作　　者：何明卫 高江原[2] 栾兴玉 郑祥奇 

机构地区：[1]重庆市第四人民医院,重庆401331 [2]重庆医药高等专科学校,重庆401300

出　　处：《河北医学》2012年第6期751-754,共4页Hebei Medicine

摘　　要：目的:探讨包含尿道灌注的综合治疗方案用于治疗慢性前列腺炎(CP)的临床效果。方法:160例门诊前列腺炎患者,年龄17-45岁,病程2-9年,均有下腹、会阴疼痛,排尿不适等症状,部分患者前列腺液(EPS)常规白细胞异常或细菌培养阳性。符合美国国立卫生研究院(NIH)制定的前列腺炎诊断标准。随机分为治疗组(A组,含尿道灌注)和对照组(B组,无尿道灌注)。经过2周洗脱后作综合治疗,对A组与B组作疗效对比分析。结果:治疗组临床治愈69例,治愈率85%;随访一年复发7例,复发率占10.10%。对照组治愈16例,治愈率20.25%;随访一年复发6例,复发率37.50%。结论:对慢性前列腺炎,含尿道灌注的综合治疗可以提高治愈率,减少或延缓复发。Objective： To investigate clinical effect of the comprehensive treatment for urethral perfusion for chronic prostatitis. Method： 160 outpatients with prostatitis were randomly divided into 2 groups： Treatment group （ Group A ） with urethral perfusion ; Control group （ Group B） , treatment as Group A without urethral perfusion. They were 17-45 years old, had lower abdomen and perineal pain, urinary discomfort and some other symptoms. Abnormal white blood cells count or bacterial culture positive in prostatic fluid was found in some patients. The diagnosis of prostatitis was in compliance with the diagnostic criteria set up by US National Institute of Health. The comprehensive treatments started after 2 weeks urethral perfusion. The clinical efficiency was compared between Group A and B. Result： In Group A, 69 cases clinically cured, The cure rate was 85% ; After l year following-up, 7 cases recurred and the recurrence rate was 10.1%. In Group B, 16 cases cured, cure rate 20.25% ; 6 cases recurred after 1 year following-up, recurrence rate 37.5%. Conclusion： Comprehensive treatment including urethral perfusion could improve the cure rate and reduce or delay recurrence in patients with chronic prostatitis.

关 键 词：慢性前列腺炎 尿道灌注 微波 综合治疗 

分 类 号：R697.3[医药卫生—泌尿科学]